Response to Nandakoban et al. Acute tubulointerstitial nephritis following treatment with exenatide. [electronic resource]
- Diabetic medicine : a journal of the British Diabetic Association Feb 2013
- 251-2 p. digital
Publication Type: Letter; Comment
1464-5491
10.1111/dme.12014 doi
Diabetes Mellitus, Type 2--drug therapy Humans Hypoglycemic Agents--adverse effects Male Nephritis, Interstitial--chemically induced Peptides--adverse effects Venoms--adverse effects